Interferon-Beta Aids Balance and Movement in Mice With Spinocerebellar Ataxia 7

The first in vivo trial of the use of interferon-beta in a mouse model of the group of fatal, neurodegenerative diseases known as spinocerebellar ataxia has shown that its use can significantly improve their physical condition and control symptoms.

Researchers in France and the US believe that their results show that a clinical trial in humans is merited.

More information at the link below:

Files

Links

http://www.sciencedaily.com/releases/2013/06/130609195625.htm

20 Ιουνίου, 2013